# The Pennant Group, Inc. (PNTG)

> Source: Nexqual · https://nexqual.com/PNTG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, The Pennant Group, Inc. (PNTG), nexqual.com/PNTG" · informational, not investment advice.

**Price:** USD 42.23 (+2.90% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 41.04 · day 41.16–42.32 · 52w 22.26–42.74 · market cap $1.48B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $1.10B, net income $32.3M (2.9% margin), free cash flow $34.7M (SEC filings).
- Valuation: P/E 45.6x (avg 34.2x at the last 3 fiscal year-ends), EV/EBITDA 22.9x, net debt $182M.
- 1 of 80 tracked superinvestors hold PNTG (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.86 on a 1–5 scale) (7 analysts), mean target USD 46.83 (range 44–49).
- Total return with dividends: 1Y +72.5% vs S&P 500 +14.9%; 5Y +77.9% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.35, revenue estimate $299M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $440M | $473M | $545M | $695M | $948M | $1.10B |
| Operating income | $4.7M | $12.7M | $25.2M | $38.1M | $51.9M | $62.2M |
| Net income | $2.7M | $6.6M | $13.4M | $22.6M | $29.6M | $32.3M |
| EPS (diluted) | $0.09 | $0.22 | $0.44 | $0.70 | $0.84 | — |
| Free cash flow | -$24.5M | -$5.1M | $25.0M | $30.3M | $36.3M | $34.7M |
| Operating margin | 1.1% | 2.7% | 4.6% | 5.5% | 5.5% | 5.6% |
| Net margin | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% | 2.9% |
| Revenue growth | +12.5% | +7.6% | +15.1% | +27.6% | +36.3% | — |
| Cash + short-term investments | $5.2M | $2.1M | $6.1M | $24.2M | $17.0M | — |
| Total debt | $51.4M | $62.9M | $63.9M | $0K | $174M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 45.6x · P/S 1.3x · EV/EBITDA 22.9x · EV/Sales 1.5x · P/FCF 42.5x · P/B 3.6x · FCF yield 2.35% · Earnings yield 2.19% · Net debt $182M · EV $1.66B
P/E at fiscal year-ends: Dec 2025 33.6x, Dec 2024 37.6x, Dec 2023 31.4x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold PNTG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.04% | $21.1M | Added +32.4% |

## Analysts
Consensus Buy (mean 1.86 on a 1–5 scale), 7 analysts; mean target USD 46.83 (low 44, high 49).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-20 | RBC Capital | Target raised | Outperform | $42 → $44 |
| 2026-08-11 | Wells Fargo | Target raised | Overweight | $45 → $46 |
| 2026-07-14 | Truist Securities | Target raised | Buy | $42 → $48 |
| 2026-07-13 | Wells Fargo | Target raised | Overweight | $41 → $45 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +72.5% | +77.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +72.8% | +12.2% |
| Volatility (annualized) | 38.1% | 51.2% |
| Max drawdown | -18.4% (May 2026→Jun 2026) | -65.0% (Nov 2021→Oct 2022) |

## Peers (Medical Care Facilities)
AGL (agilon health, inc.) USD 90.29 -0.77% · NUTX (Nutex Health Inc.) USD 206.09 +4.29% · CMPS (COMPASS Pathways Plc - American) USD 11.63 -1.77% · SNDA (Sonida Senior Living, Inc.) USD 33.87 +1.20% · USPH (U.S. Physical Therapy, Inc.) USD 88.73 +2.84% · HCSG (Healthcare Services Group, Inc.) USD 24.79 +14.19%

## More
Full page: https://nexqual.com/PNTG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.35 | $0.34 | +2.9% | $299.5M | 7 |
| Next quarter (ends 2026-12-31) | $0.37 | $0.36 | +0.8% | $303.9M | 7 |
| Current fiscal year (ends 2026-12-31) | $1.40 | $1.35 | +3.5% | $1.18B | 7 |
| Next fiscal year (ends 2027-12-31) | $1.59 | $1.60 | -0.7% | $1.28B | 7 |